Entering text into the input field will update the search result below

Gb Sciences gets US patent for cannabinoid-containing mixture to treat heart disease

Mar. 01, 2022 8:57 AM ETGB Sciences, Inc. (GBLX)By: Ravikash, SA News Editor

Human Heart

Eoneren/E+ via Getty Images

  • Gb Sciences (OTCQB:GBLX) was issued a new patent by the U.S. Patent and Trademark Office (USPTO) for a cannabinoid-containing mixture designed to treat cardiac hypertrophy, often present in advanced heart disease.
  • Cardiac hypertrophy is the enlargement and thickening

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.